Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Browse Other Projects on Experiment
Related Projects
A scientific approach to placenta remedies: What hormones are found in placenta tissue?
The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...
The Effects of Sudarshan Kriya Yoga (SKY) in patients with Post Traumatic Stress Disorder (PTSD)
Sudarshan Kriya Yoga (SKY) is a standardized series of breathing techniques that has beneficial effects...
Circulating biomarkers of fibrosis in captive gorillas: a pilot study
Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...